Header Logo

Connection

John Steiner to Medication Adherence

This is a "connection" page, showing publications John Steiner has written about Medication Adherence.
Connection Strength

4.648
  1. Using Adherence Information to Improve Care: From Clinic Visits to Populations. J Gen Intern Med. 2016 11; 31(11):1272-1273.
    View in: PubMed
    Score: 0.445
  2. Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes. J Gen Intern Med. 2016 Feb; 31(2):188-195.
    View in: PubMed
    Score: 0.423
  3. Measuring adherence with medications: time is of the essence. Pharmacoepidemiol Drug Saf. 2016 Mar; 25(3):333-5.
    View in: PubMed
    Score: 0.421
  4. Impact on glycated haemoglobin of a biological response-based measure of medication adherence. Diabetes Obes Metab. 2015 Sep; 17(9):843-8.
    View in: PubMed
    Score: 0.403
  5. Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes. Diabetes Care. 2014 Dec; 37(12):3317-24.
    View in: PubMed
    Score: 0.386
  6. Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases. Med Care. 2013 Aug; 51(8 Suppl 3):S11-21.
    View in: PubMed
    Score: 0.355
  7. Self-reported adherence measures: what do they assess and how should we use them? Med Care. 2012 Dec; 50(12):1011-2.
    View in: PubMed
    Score: 0.339
  8. Rethinking adherence. Ann Intern Med. 2012 Oct 16; 157(8):580-5.
    View in: PubMed
    Score: 0.336
  9. Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders. J Gen Intern Med. 2012 Jan; 27(1):57-64.
    View in: PubMed
    Score: 0.311
  10. Can we identify clinical predictors of medication adherence... and should we? Med Care. 2010 Mar; 48(3):193-5.
    View in: PubMed
    Score: 0.280
  11. Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension. Circ Cardiovasc Qual Outcomes. 2009 Sep; 2(5):451-7.
    View in: PubMed
    Score: 0.270
  12. Effect of Values Affirmation on Reducing Racial Differences in Adherence to Hypertension Medication: The HYVALUE Randomized Clinical Trial. JAMA Netw Open. 2021 12 01; 4(12):e2139533.
    View in: PubMed
    Score: 0.158
  13. A randomized clinical trial of an interactive voice response and text message intervention for individuals with hypertension. J Clin Hypertens (Greenwich). 2020 07; 22(7):1228-1238.
    View in: PubMed
    Score: 0.143
  14. Health care system-level factors associated with performance on Medicare STAR adherence metrics in a large, integrated delivery system. Med Care. 2015 Apr; 53(4):332-7.
    View in: PubMed
    Score: 0.100
  15. An investigation of associations between clinicians' ethnic or racial bias and hypertension treatment, medication adherence and blood pressure control. J Gen Intern Med. 2014 Jul; 29(7):987-95.
    View in: PubMed
    Score: 0.092
  16. Simultaneous control of diabetes mellitus, hypertension, and hyperlipidemia in 2 health systems. Circ Cardiovasc Qual Outcomes. 2012 Sep 01; 5(5):645-53.
    View in: PubMed
    Score: 0.083
  17. Relationship Between Social Vulnerability Indicators and Trial Participant Attrition: Findings From the HYVALUE Trial. Circ Cardiovasc Qual Outcomes. 2022 May; 15(5):e007709.
    View in: PubMed
    Score: 0.041
  18. Medicare Star excludes diabetes patients with poor CVD risk factor control. Am J Manag Care. 2014 Dec 01; 20(12):e573-81.
    View in: PubMed
    Score: 0.024
  19. A comparison of different measures of acculturation with cardiovascular risk factors in Latinos with hypertension. J Immigr Minor Health. 2011 Apr; 13(2):284-92.
    View in: PubMed
    Score: 0.019
  20. Antiretroviral medication adherence and the development of class-specific antiretroviral resistance. AIDS. 2009 Jun 01; 23(9):1035-46.
    View in: PubMed
    Score: 0.017

© 2025 Kaiser Permanente